Confronting Inequities in STI Prevention, Diagnostics and Care
Track 2: Prevention and Behavioural Science
Chairperson, South Africa
Sinead Delany-Moretlwe, MBBCh PhD DTM&H is a Research Professor and Director: Research, Wits RHI at the University of the Witwatersrand, Johannesburg. Her research interests span the intersections between sexual and reproductive health and infectious diseases, particularly among adolescent girls and young women. She has worked on several phase III trials of new HIV prevention technologies, including oral, topical and most recently long-acting injectable PrEP. She is also principal investigator on a population impact evaluation of the HPV vaccination programme in South Africa. She has served on the South African National Department of Health PrEP technical working group, and several WHO advisory committees, including PDVAC.
Frances Cowan is a clinical epidemiologist and Professor of Global Health at the Liverpool School of Tropical Medicine. She is based in Zimbabwe where she is the Executive Director of the Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, leading a portfolio of HIV prevention research, which includes large scale impact evaluations of national HIV programmes.
Maria Eugenia Escobar
Specialist in Gynecology and Obstetrics, Ministry of Health of Argentina. Specialist in Child and Adolescent Gynecology, SAGIJ. Argentina President of ASAIGO ITS. Argentine Society for the Study of Ob-Gyn Infections and STI Control. Argentina
Professional activity focuses in the outpatient clinics of the Mater Dei Sanatory, Buenos Aires, Private office in Buenos Aires, Client face-to-face and online consultations, as well as Psychoeducation Workshops online and throughout the country, mainly dedicated to vulnerable populations.
Dr Sami Gottlieb is a Medical Officer in the Department of Sexual and Reproductive Health and Research at the World Health Organization in Geneva, where she works on multiple aspects of the global prevention and control of sexually transmitted infections (STIs) and on vaccine development and implementation related to sexual and reproductive health. She has a particular focus on STI vaccine development and maternal immunization, including COVID-19 vaccination during pregnancy.
Professor Nelly R. Mugo is a Senior Principal Clinical Research Scientist at the Kenya Medical Research Institute (KEMRI), Associate Research Professor, Department of Global Health at the University of Washington and a reproductive health specialist with three decades of work experience. Her research focus has been on prevention of HIV and cervical cancer. She has been an investigator on the Partners PrEP study that contributed evidence to inform the change of indication for use of Truvada as HIV prevention pre-exposure prophylaxis (PrEP), and a protocol lead for the on-going ‘Kenya Single-dose HPV Vaccine-Efficacy (KEN SHE) Study’ that has provided evidence on efficacy of single dose HPV vaccination.
Dr Kenneth Ngure is an Associate Professor of Global Health and the Chair, Department of Community Health of Jomo Kenyatta University of Agriculture and Technology (JKUAT), Kenya. He is also an Affiliate Associate Professor of the Department of Global Health, University of Washington. He is a behavioral Scientist affiliated with the Microbicide Trials Network (MTN), The HIV Prevention Trial Network (HPTN), International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT) and, more recently, the HIV/AIDS Network Coordination (HANC).
Dr Danielle Travill is a research clinician at Wits RHI, Johannesburg, South Africa. Her work focuses mainly on sexual and reproductive health and sexually transmitted infections, with a passion for primary health care. Combining her clinical background with her experience in research, her work focuses on implementing evidence-based research in real world contexts.
Ariane van der Straten
Professor Ariane van der Straten is an Adjunct Professor at the University of California San Francisco (UCSF) School of Medicine, Center for AIDS Prevention Studies, and an independent investigator and consultant through ASTRA consulting. Over the past 25 years, she has researched women’s sexual and reproductive health issues globally with a focus on developing methods to prevent HIV, and/or unplanned pregnancies. She combines biomedical and socio-behavioural research to better understand and assess adherence to, and acceptability of biomedical prevention methods.